期刊文献+

反义寡核苷酸对人淋巴瘤细胞系Namalwa细胞血管内皮生长因子表达影响的体外研究(英文)

Effect of Antisense Oligodeoxynucleotides on the Expression of Vascular Endothelial Growth Factor in Namalwa cell In Vitro
下载PDF
导出
摘要 为了研究硫代磷酸化修饰的血管内皮生长因子(vascular endothelial growth factor,VEGF)反义寡核苷酸(antisense oligodeoxynucleotide,ASODN)对人淋巴瘤细胞系Namalwa细胞VEGF表达的影响,将终浓度分别为5、10、20μmol/L的VEGFASODN和错义序列与人淋巴瘤细胞系Namalwa细胞分别孵育24、48小时,采用RT-PCR检测VEGFmRNA的表达,采用链酶菌抗生素蛋白-过氧化酶免疫组织化学法(streptavidin/peroxidase,SP法)检测VEGF的表达。结果表明:VEGFASODN3个浓度组(5、10和20μmol/L)处理的Namalwa细胞VEGFmRNA的表达分别为1.38、0.96、0.57,错义序列组和对照组分别为1.79、1.84。当加入20μmol/LVEGFASODN作用48小时后,细胞内VEGF蛋白水平显著减少,而错义序列组Namalwa细胞VEGF蛋白水平未见明显改变。结论:VEGFASODN在体外能够抑制Namalwa细胞VEGF的表达。 In order to study the effects of phosphorothioated antisense oligodeoxynucleotides (ASODN) on the expression of VEGF in human lymphoma cell line Namalwa cells, human lymphoma cell line Namalwa cells were incubated with VEGF ASODN (the final concentrations of VEGF ASODN were 5, 10, 20 μmol/L respectively ), or scrambled sequence for 24 or 48 hours. The expressions of VEGF mRNA and VEGF protein were detected by reverse transcriptase-polymerase chain reaction and streptavidin peroxidase (SP) immunohistochemistry respectively. The results showed that the expression levels of VEGF mRNA in Namalwa cells treated with three concentration levels (5,10, 20μmol/L of ASODN) were 1.38, 0.96 and 0.57 respectively. Those in PBS-treated cells and scrambled sequence treated cells were 1. 79 and 1. 84. When treated with 20 μmol/L VEGF ASODN for 48 hours, VEGF protein of Namalwa cells decreased greatly. Meamwhile, there was no obvious change in the scrambled sequence treated group. It is concluded that VEGF ASODN can suppress the VEGF expression in Namalwa cells in vitro.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第4期854-857,共4页 Journal of Experimental Hematology
关键词 血管内皮生长因子 反义寡核苷酸 Namalwa细胞 淋巴瘤 vascular endothelial growth factor antisense oligodeoxynucleotide namalwa cell lymphoma
  • 相关文献

参考文献9

  • 1Ho CL,Sheu LF,Li CY.Immunohistochemical expression of basic fibroblast growth factor,vascular endothelial growth factor,and their receptors in stage Ⅳ non-Hodgkin lymphoma.Appl Immunohistochem Mol Morphol,2002; 10:316-321
  • 2Potti A,Ganti AK,Kargas S,et al.Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF)overexpression in mantle cell lymphoma.Anticancer Res,2002; 22:2899-2901
  • 3Bellamy WT,Richter L,Frutiger Y,et al.Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.Cancer Res,1999; 59:728 -733
  • 4Masood R,Cai J,Zheng T,et al.Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.Proc Natl Acad Sci,1997; 94:979 -984
  • 5Soker S,Gollamudi-Payne S,Fidder H,et al.Inhibition of vascular endothelial growth factor(VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.J Biol Chem,1997; 272:31582-31588
  • 6Plate KH,Breier G,Weich HA,et al.Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.Nature,1992; 359(6398):845 -848
  • 7童允洁,张敏,邹萍,郭荣.VEGF硫代反义寡核苷酸抑制U937细胞VEGF的表达[J].中国实验血液学杂志,2004,12(2):151-153. 被引量:3
  • 8Gasparini G,Toi M,Gion M,et al.Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.J Natl Cancer Inst,1997; 89:139-147
  • 9Nguyen JT,Wu P,Clouse ME,et al.Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy.Cancer Res,1998; 58:5673 -5677

二级参考文献7

  • 1Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest,1989;84:1470-1478
  • 2Shi W, Siemann DW. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor. BrJ Cancer,2002;87:119-126
  • 3Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc. Natl.Acad. Sci. USA,1997;94:979-984
  • 4Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukaemia. Blood,1997;89:1870-1875
  • 5Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood,2000;95:2637-2644
  • 6Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res,1999;59:728-733
  • 7Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood,2000;95:309-313

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部